Invitro & Invivo Diagnostic

TrilliumBiO and T-NeuroDx Partner to Advance Blood-Based Diagnostics for Early Alzheimer’s Detection

Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease ...

Aptitude Medical Secures $9M BARDA Partnership to Advance Rapid Filovirus Diagnostic for Ebola and Marburg Detection

New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness. ...

The FDA Is Phasing Out Animal Testing

As regulatory shifts accelerate, next-generation non-animal models must rapidly evolve to ensure safety, efficacy, and innovation in human drug development....

Fulgent Genetics Secures EU CE Mark for FulgentExome and FulgentPLM

Certification Advances Global Access to Comprehensive Genetic Testing and Precision Medicine Solutions in Europe...

Overture Life Signs Agreement With Memorial Hospital Istanbul for World’s First Commercial Automated IVF Technology

Pioneering collaboration introduces next-generation automation to reproductive medicine, marking a breakthrough in accessible and standardized IVF care....

Oncomine Dx Express Test Gains FDA Approval, Expanding Thermo Fisher’s Precision Oncology Portfolio

The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....

Artience Launches Functional Synthetic Polymers for Enhanced In Vitro Diagnostic Performance

Breakthrough polymer platform aims to improve sensitivity, stability, and efficiency across diagnostic assays and lab workflows....

Thermo Fisher’s NGS-Based Oncomine Dx Express Test Gains FDA Approval

FDA clears assay as companion diagnostic for ZEGFROVY™ and broad tumor profiling, advancing precision oncology diagnostics....

ProNephro AKI (NGAL) Test Enters U.S. Market for Diagnostic Use

Commercial Launch Marks a Key Step in Enhancing Early Detection of Acute Kidney Injury through Biomarker-Based Testing ...

Mursla Bio Unveils AI-Powered Precision Medicine Platform Leveraging Organ-Specific EVs

New technology isolates extracellular vesicles from blood to enable earlier, non-invasive disease detection and personalized treatment strategies....